Navigation Links
Two Sepsis Treatments Look Equally Effective
Date:2/23/2010

Study attempts to settle ongoing debate

TUESDAY, Feb. 23 (HealthDay News) -- Two treatment methods for severe sepsis achieve similar short-term survival rates, a new study shows.

Researchers at the Carolinas Medical Center in Charlotte, N.C., compared lactate clearance (using lactate levels measured in blood samples) with a treatment involving central venous oxygen saturation (ScvO2) measured using a catheter connected to a computerized system. The Surviving Sepsis Campaign guidelines recommend the use of ScvO2, but there is ongoing debate about which of the two methods is better.

The study looked at outcomes of early resuscitation in 300 patients with either severe sepsis and evidence of hypoperfusion (decreased blood flow to the body tissues) or septic shock who were admitted to a hospital emergency department and randomly assigned to receive one of the two treatments.

The Carolinas Medical Center team found that 34 patients (23 percent) in the ScvO2 group died while in hospital, compared with 25 (17 percent) of patients in the lactate clearance group. There were no differences in treatment-related adverse events.

"These data support the substitution of lactate measurements in peripheral venous blood as a safe and efficacious alternative to a computerized spectrophotometric catheter in the resuscitation of sepsis," the researchers concluded.

The study appears in the Feb. 24 issue of the Journal of the American Medical Association.

Each year in the United States, at least 750,000 people are hospitalized with severe sepsis, and about 500,000 of them are initially treated in emergency departments.

More information

The U.S. National Institute of General Medical Sciences has more about sepsis.



-- Robert Preidt



SOURCE: Journal of the American Medical Association, news release, Feb. 23, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Scientists Probe Sepsis Deadly Secrets
2. Blacks More Likely to Die of Severe Sepsis
3. Research May Yield New Weapons Against Sepsis
4. Customized treatments for sepsis lower treatment time and reduce length of ICU stays
5. Ashwell receptor reduces mortality during sepsis
6. Educational Drive Cut Death Rate From Sepsis
7. Medical Simulation Corporation Introduces Sepsis Quality Initiative Program
8. Sepsis Therapy in Preemies Fails to Boost Survival
9. Children's National Research Links Platelets to Sepsis-Related Organ Failure
10. Vanderbilt researchers pioneer an advanced sepsis detection and management system
11. Sepsis Treatment Offers Lifesaving Potential
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... ... April 29, 2017 , ... TransDark is a set ... one video to the next without having to set a single keyframe in ... to enhance your video production. , TransDark features dynamic transitions that momentarily splits the ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... An April 24th article on ... stunning 180 pounds with the help of a weight loss surgery. The woman, declaring “I ... skin that have been left following her dramatic weight loss. Dr. Feiz & Associates notes ...
(Date:4/28/2017)... , ... April 28, 2017 , ... Beginning in 2017, ... their formulas. This begins with the popular ClearLungs Extra Strength formula. To ensure that ... the formula in the following ways:, , Removal of the ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
(Date:4/28/2017)... ... April 28, 2017 , ... From ... College of Urgent Care Medicine will host industry leaders for the annual spring ... help those in the industry adapt to the issues currently affecting urgent care ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 20, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... the Urology, Uro/Gyn and Gynecology markets with innovative ... has joined the Company as Senior Vice President, ... position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has joined ...
(Date:4/20/2017)... , April 20, 2017  RXi Pharmaceuticals Corporation ... therapeutics that address significant unmet medical needs, today ... the Company,s consumer product development program, based on ... Society for Investigative Dermatology (SID) 76 th ... and promote the sciences relevant to skin health ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ... 99 percent (n=145/146) of chronic hepatitis C virus ... 5 or 6 and compensated cirrhosis (Child-Pugh A) ... (SVR 12 ) with its investigational, pan-genotypic regimen ... rates were seen following 12 weeks of G/P ...
Breaking Medicine Technology: